InVivo Therapeutics Corporation Files FDA Application for Human Studies for Spinal Cord Injury Treatment
CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Corporation has filed an Investigational Device Exemption application with the Food and Drug Administration requesting permission to advance to human clinical studies. InVivo is currently conducting its third primate study and expects to receive approval to begin a human study in 2010.
More: http://www.your-stor...reatment-63929/
Invivo Therapeutics Corporation Files Fda Application
Started by
Apparelyzed
, Dec 08 2009 03:50 PM
1 reply to this topic
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users






Top








